Prevalence and Progression of Subtypes of Gastric Premalignant Lesions: A Systematic Review and Meta-Analysis
Clinical Gastroenterology and Hepatology · 2026-09
DOI: 10.1016/j.cgh.2026.08.020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-09. Verfasst von Yendé Grell und 17 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medical College of Cornell University, New York, New York. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
BACKGROUND & AIMS: Gastric intestinal metaplasia (IM) and dysplasia are precursor lesions for gastric cancer. This systematic review and meta-analysis examined the global prevalence and progression rates of subtypes of these understudied lesions. METHODS: We searched databases for publications reporting prevalence and progression of subtypes of IM and dysplasia among individuals undergoing endoscopy, including incomplete/complete IM, limited (antrum-restricted)/extensive (corpus-involving) IM, and low-grade dysplasia (LGD) and high-grade dysplasia (HGD). Random-effects models were used to estimate pooled prevalence and progression rates to gastric cancer. The I2 statistic was used to determine heterogeneity. RESULTS: Eighty-three studies were included for prevalence and 23 for progression. The prevalence of complete IM was 11% (95% confidence interval [CI], 8%-15%) and of incomplete IM was 10% (95% CI, 6%-14%), with corresponding progression rates of 1.73 (95% CI, 1.08-2.79) vs 12.15 (95% CI, 5.28-27.94) per 1000 person-years, respectively (P < .01). The prevalence of limited vs extensive IM was 12% (95% CI, 8%-17%) vs 5% (95% CI, 4%-8%), respectively, and the corresponding progression rates were 3.31 (95% CI, 1.18-9.32) vs 4.19 (95% CI, 0.95-18.41) per 1000 person-years (P = .80). The prevalence of LGD was 2% (95% CI, 1%-4%) and of HGD was 0.28% (95% CI, 0.14%-0.55%), with corresponding progression rates of 11.55 (95% CI, 5.93-22.47) vs 344.48 (95% CI, 144.88-819.09; P < .01). Substantial heterogeneity was observed for all estimates. CONCLUSIONS: Although lesion subtypes with high progression risk like incomplete IM account for a large portion of the total burden of precancerous lesions, subtyping remains underutilized in clinical practice. Although estimates are limited by heterogeneity, differences in progression rates between lesion subtypes support risk stratification of these lesions within management guidelines, particularly complete vs incomplete IM and LGD vs HGD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Weill Cornell Medical College of Cornell University, New York, New York.
- Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands.
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
- Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands; School of Economics, University College Dublin, Dublin, Ireland.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- National Institutes of Health National Cancer Institute
- National Institutes of Health
Zitieren
APA
Grell, Y., Mülder, D. T., Hahn, A. I., Huang, R. J., Zhou, M. J., Blake, B., Omofuma, O., Murphy, J. D., Gutiérrez-Torres, D. S., Zauber, A. G., O'Mahony, J. F., Camargo, M. C., Ladabaum, U., Yeh, J. M., Hur, C., Lansdorp-Vogelaar, I., Meester, R., & Laszkowska, M. (2026). Prevalence and Progression of Subtypes of Gastric Premalignant Lesions: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2026.08.020
Vancouver
Grell Y, Mülder DT, Hahn AI, Huang RJ, Zhou MJ, Blake B, et al. Prevalence and Progression of Subtypes of Gastric Premalignant Lesions: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology. 2026. doi:10.1016/j.cgh.2026.08.020
BibTeX
@article{Grell2026,
author = {Grell, Yendé and Mülder, Duco T and Hahn, Anne I and Huang, Robert J and Zhou, Margaret J and Blake, Benjamin and Omofuma, Omonefe and Murphy, John D and Gutiérrez-Torres, Daniela S and Zauber, Ann G and O'Mahony, James F and Camargo, M Constanza and Ladabaum, Uri and Yeh, Jennifer M and Hur, Chin and Lansdorp-Vogelaar, Iris and Meester, Reinier and Laszkowska, Monika},
title = {Prevalence and Progression of Subtypes of Gastric Premalignant Lesions: A Systematic Review and Meta-Analysis},
journal = {Clinical Gastroenterology and Hepatology},
year = {2026},
doi = {10.1016/j.cgh.2026.08.020}
}
EUVIMED